[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-354811-105":59,"doc-detail-354811-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","guanylate-binding-protein-2-gbp2-drives-pancreatic-cancer-cell-proliferation-via-the-sp1skp2p27-axis","Guanylate-binding protein 2 (GBP2) drives pancreatic cancer cell proliferation by promoting cell cycle progression via the SP1/SKP2/P27 axis","","Guanylate-binding protein 2 (GBP2) is implicated in multiple malignancies, yet its specific roles and molecular mechanisms in pancreatic cancer remain unclear. This study quantified GBP2 in pancreatic cancer tissues and cell lines, correlating its expression with clinicopathological features and patient outcomes. In vitro and in vivo experiments evaluated GBP2’s effects on proliferation and cell-cycle progression, while RNA-sequencing and mechanistic assays identified downstream targets and regulatory interactions, clarifying the GBP2-dependent SP1/TRIM25/SKP2/p27 axis.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/guanylate-binding-protein-2-gbp2-drives-pancreatic-cancer-cell-proliferation-via-the-sp1skp2p27-axis/354811/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/guanylate-binding-protein-2-gbp2-drives-pancreatic-cancer-cell-proliferation-via-the-sp1skp2p27-axis/354811.png","ImageObject",300,407,{"name":92,"@type":93},"MrHarris58","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-19","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":44},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What was the main focus of the study on GBP2 in pancreatic cancer?","Question",{"text":112,"@type":113},"The study examined how GBP2 affects pancreatic cancer cell proliferation and cell cycle progression and identified the molecular mechanism behind these effects.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How did researchers assess GBP2 expression and its clinical relevance?",{"text":117,"@type":113},"GBP2 levels were measured in pancreatic cancer tissues and cell lines, and the association between GBP2 expression, clinicopathological features, and patient prognosis was analyzed.",{"name":119,"@type":110,"acceptedAnswer":120},"What mechanism links GBP2 to cell-cycle progression through SP1/SKP2/p27?",{"text":121,"@type":113},"GBP2 competes with TRIM25 for binding to SP1, reducing SP1 ubiquitination and degradation; stabilized SP1 then enhances SKP2 transcription, activating the SKP2/p27 axis to promote tumor progression.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},354811,1791192556,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":44,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":56,"language":139,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":140,"faqs":141,"seo_title":142,"seo_description":67,"update_tm":143,"read_time":144,"preview_page_count":19,"preview_urls":145},687212988360,"https://ap-avatar.wpscdn.com/davatar_276721f389ce27ea32af1340a28f341c","Fang et al. Journal of Translational Medicine (2026) 24:1189  \n[https://doi.org/10.1186/s12967-026-08815-6](https://doi.org/10.1186/s12967-026-08815-6)  \nJournal of Translational Medicine  \nRESEARCH Open Access  \nGuanylate-binding protein 2 (GBP2) drives pancreatic cancer cell proliferation by promoting cell cycle progression via the SP1/SKP2/P27 axis  \nShilin Fang1,2†, Haihang Nie3†, Jingkai Zhou4,5,6†, Yongxi Zhang2†, Xiaoping Liu7, Jianchun Guo7, Yuntian Hong4,5,6, Yang Ding4,5,6, Yumei Ning4,5,6, Fan Wang4,5,6, Hengning Ke2,8*, Jun Fang1* and Haizhou Wang4,5,6*  \nAbstract  \nBackground Guanylate-binding protein 2 (GBP2) has been reported to be involved in the progression of various human malignancies, but its specific functions and underlying molecular mechanisms in pancreatic cancer remain poorly understood.  \nMethods The expression level of GBP2 in pancreatic cancer tissues and cell lines was detected, and the correlation between GBP2 expression and clinicopathological features as well as patient prognosis was analyzed. In vitro and in vivo experiments were performed to investigate the effect of GBP2 on pancreatic cancer cell proliferation and cell cycle progression. RNA-sequencing was conducted to screen downstream regulatory targets of GBP2, and molecular mechanism assays (including ubiquitination assay, co-immunoprecipitation) were carried out to verify the regulatory relationship between GBP2, SP1, TRIM25 and SKP2 .  \nResults GBP2 was significantly upregulated in pancreatic cancer tissues and cell lines, and high GBP2 expression was closely associated with a poor prognosis, an advanced TNM stage and a higher tumor grade. Functional experiments showed that GBP2 promotes pancreatic cancer cell proliferation by inducing cell cycle progression. Mechanistically, GBP2 competes with the E3 ubiquitin ligaseTRIM25 for binding to transcription factor SP1, thereby inhibiting SP1 ubiquitination and proteasomal degradation. The stabilized SP1 further enhances its binding to the SKP2 promoter, upregulates SKP2 transcription, and activates the SKP2/p27 signaling axis to drive tumor progression.  \n†Shilin Fang, Haihang Nie, Jingkai Zhou and Yongxi Zhang contributed equally to this work.  \n*Correspondence: Hengning Ke[kehengning@znhospital.cn](kehengning@znhospital.cn)[ ](kehengning@znhospital.cn)Jun Fang[xhfangjun@163.com](xhfangjun@163.com)[ ](xhfangjun@163.com)Haizhou Wang [whzcj@outlook.com](whzcj@outlook.com)  \nFull list of author information is available at the end of the article  \n© The Author(s) 2026. Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit [http://creati](http://creati)[vecommons.org/licenses/by-nc-nd/4.0/](vecommons.org/licenses/by-nc-nd/4.0/.)[.](vecommons.org/licenses/by-nc-nd/4.0/.)  \nFang et al. Journal of Translational Medicine (2026) 24:1189 Page 2 of 19  \nConclusions This study reveals a novel GBP2–SP1–SKP2–p27 signaling pathway that promotes pancreatic cancer progression. GBP2 may serve as a potential therapeutic target for pancreatic cancer, which requires further validation through pharmacological stu","cbCaijOgRQKNzwoj","https://ap.wps.com/l/cbCaijOgRQKNzwoj","pdf",12346913,"English","# Abstract\n## Background\n## Methods\n## Results\n## Conclusions\n# Introduction\n## Disease context and prognosis\n## GBP2 roles across cancers\n# Authors and publication details","[{\"question\":\"What was the main focus of the study on GBP2 in pancreatic cancer?\",\"answer\":\"The study examined how GBP2 affects pancreatic cancer cell proliferation and cell cycle progression and identified the molecular mechanism behind these effects.\"},{\"question\":\"How did researchers assess GBP2 expression and its clinical relevance?\",\"answer\":\"GBP2 levels were measured in pancreatic cancer tissues and cell lines, and the association between GBP2 expression, clinicopathological features, and patient prognosis was analyzed.\"},{\"question\":\"What mechanism links GBP2 to cell-cycle progression through SP1/SKP2/p27?\",\"answer\":\"GBP2 competes with TRIM25 for binding to SP1, reducing SP1 ubiquitination and degradation; stabilized SP1 then enhances SKP2 transcription, activating the SKP2/p27 axis to promote tumor progression.\"}]","Guanylate-binding protein 2 (GBP2) drives pancreatic cancer cell proliferation by promoting cell cycle progression via the SP1/SKP2/P27 axis | PDF",1790114133,48,[146,150,154,158],{"page_no":8,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/fb835174684409a67b47cc156e4bb40b.webp",983,1310,{"page_no":14,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/38fe988cf974fc36853d3316fbde8561.webp",982,1309,{"page_no":81,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/89a24dfdd8010aecd49ed806c20d3169.webp",981,1308,{"page_no":19,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/8559365f9b938ce6515f178828584c8c.webp",980,1306]